Oklahoma Cancer Specialists and Research Institute

Name

Oklahoma Cancer Specialists and Research Institute

Legal name

Oklahoma Cancer Specialists and Research Institute

Website

https://ocsri.org

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Oncology and Cancer Care Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industries

Surgical Oncology (HLAKAFAG), Gynecologic Oncology (HLAKAFAF)

Keywords

• Oncology treatment services
• Radiation oncology therapy
• Clinical research trials
• Cancer diagnostic imaging
• Specialty pharmacy services

Headquarters

HQ city

Tulsa

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Patient Care Services: Fee-for-service healthcare delivery model covering medical oncology, radiation oncology, surgical oncology, diagnostic radiology, clinical research, pharmacy, and laboratory services. Revenue is generated through insurance billing, patient payments, and potentially federal/grant funding for research.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Oklahoma Cancer Specialists and Research Institute is a community-based physician-owned oncology practice providing comprehensive cancer care across diagnosis, treatment, and survivorship. Services span medical oncology, radiation oncology, surgical oncology, gynecologic oncology, hematology, skin cancer treatment (including Mohs surgery), diagnostic radiology, and mammography, supported by an in-house specialty pharmacy, accredited laboratory, clinical research program, and integrative care services delivered across five Oklahoma facilities.

Product overview

Oklahoma Cancer Specialists and Research Institute (OCSRI) is a comprehensive community-based oncology practice providing integrated cancer care services. The organization operates as a unified platform offering core clinical services (Medical Oncology, Breast Oncology, Gynecologic Oncology, Hematology, Radiation Oncology, Skin Cancer/Cutaneous Oncology, Mohs Surgery, Diagnostic Radiology, Clinical Research) complemented by support services (Retail Pharmacy, In-House Laboratory, Nurse Educator, Nutrition Services, Integrative Services via the Hope & Healing program, and Mammography). The institute integrates clinical research directly into patient care and has partnered with technology providers like MiBA for real-time data analytics and AllyGPO for AI-powered drug management to enhance operational efficiency.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Oncology

Quantifiable outcome

• 35-day improvement in rebate payment timing, 75% reduction in drug ordering time, 10% reduction in inventory days on hand, and 99% drug audit accuracy through AllyGPO AI-powered practice intelligence
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature4 records

Partnerships

Eleven partnerships are on record, tiered core, major and minor.

• Meaningful Insights Biotech Analytics LLC (MiBA)coreTechnology or Integration · 1 April 2026MiBA and OCSRI announced a strategic partnership in April 2026 to integrate MiBA's real-time data platform into OCSRI's clinical operations, enabling physicians to access actionable insights for treatment planning and clinical trial matching at the point of care. The collaboration aims to shorten time from study feasibility to first patient enrollment for Phase I, II, and III trials while expanding patient access to cutting-edge therapies locally without requiring travel to distant academic centers.
• IDEOlogy HealthmajorStrategic or Co-development Partner · 1 October 2025OCSRI partnered with IDEOlogy Health in October 2025 to provide multi-channel non-promotional medical education for healthcare providers. The collaboration includes access to educational platforms like Sound Bites and IDEO Talks to improve clinical insights and patient care, enhancing oncology education and supporting clinical outcomes for patients within the network.
• AllyGPOcoreStrategic or Co-development Partner · 1 June 2025AllyGPO, a specialty group purchasing organization, partnered with OCSRI in June 2025 to integrate AI-powered practice intelligence tools for drug purchasing, rebate management, and inventory optimization. Key performance improvements include 35-day improvement in rebate payment timing, 75% reduction in drug ordering time, 10% reduction in inventory days on hand, and 99% drug audit accuracy. The collaboration addresses community oncology practices seeking alternatives to legacy GPO models offering limited transparency and innovation.
• Ascension St. John Medical CentercoreStrategic or Co-development PartnerAscension St. John Medical Center in Tulsa, Oklahoma is the clinical partner where St. John Medical Center and Tulsa Cancer Institute formed OCSRI in 2016. The hospital delivers specialty and 24/7 emergency care with a Level 1 Trauma Center. OCSRI provides cancer care services at the St. John campus including in-house laboratory, retail pharmacy, and multiple physician providers.
• ElektacoreTechnology or IntegrationOCSRI is a designated Elekta reference site, offering a broad range of state-of-the-art hardware and software products to expand radiation therapy options. Elekta technology supports OCSRI's precision radiation therapy capabilities.
• C-RADcoreTechnology or IntegrationC-RAD technology offers non-invasive tracking mechanisms to monitor patient movements and breathing during radiation treatment. Combined with Elekta, it provides surface positioning and intrafraction motion management, automatically pausing treatment if patient movement exceeds pre-set thresholds.
• NRG OncologycoreStrategic or Co-development PartnerOCSRI is a member of NRG Oncology, one of the leading national research networks conducting clinical trials in radiation oncology, gynecologic oncology, and breast cancer. Membership provides access to cutting-edge clinical trials and research collaborations.
• Quality Cancer Care Alliance (QCCA)majorStrategic or Co-development PartnerOCSRI is affiliated with Quality Cancer Care Alliance, a network of oncology practices focused on quality standards and best practices in cancer care delivery.
• Oncare AllianceminorStrategic or Co-development PartnerOCSRI is a member of Oncare Alliance, an initiative of the American Medical Association focused on oncology care delivery models and best practices.
• American Society for Radiation Oncology (ASTRO)coreStrategic or Co-development PartnerOCSRI's radiation department has been accredited through ASTRO's APEx – Accreditation Program for Excellence, a voluntary and rigorous multi-step process validating radiation oncology facility excellence in delivering safe, high-quality patient care.
• American Society of Clinical Oncology (ASCO)coreStrategic or Co-development PartnerOCSRI is ASCO Certified, meeting comprehensive evidence-based oncology medical home standards, and is QOPI Certified. OCSRI supports ASCO's efforts to bring awareness to the importance of federal funding for cancer research.

Scale indicators6 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• OneOncology: National platform of independent community oncology practices offering technology, purchasing, and clinical research support. Directly comparable physician-owned, technology-enabled community oncology model.
• Alliance Cancer Specialists: Community-based hematology-oncology practice offering chemotherapy, radiation, imaging, lab, and clinical research. Comparable multi-site physician-owned community oncology model.
• US Oncology Network (McKesson): Largest national network of community-based oncology practices, also affiliated with NRG Oncology. Closest comparable to OCSRI's physician-owned, community-delivered model with research integration.
• Texas Oncology: Large multi-site community oncology practice affiliated with US Oncology Network offering medical oncology, radiation oncology, and clinical trials. Closely comparable regional multi-site cancer care delivery model.

Others

• Clearwave: OCSRI's patient check-in technology partner enabling mobile pre-check. Adjacent vendor enabling patient experience and front-desk efficiency.
• Elekta: OCSRI's designated radiation oncology technology partner and reference site relationship. Adjacent vendor providing hardware/software underpinning OCSRI's radiation therapy offering.

Regional players

• OU Health Stephenson Cancer Center: Oklahoma's only NCI-designated cancer center, based at the University of Oklahoma in Oklahoma City. Direct Oklahoma competitor for complex oncology cases, clinical trials, and academic referrals.

Peers

• Florida Cancer Specialists & Research Institute: Large physician-owned community oncology practice with research program. Comparable scope of medical/hematology/gynecologic oncology plus clinical trials across multiple Florida locations.

Broad incumbents

• Sarah Cannon Research Institute (HCA Healthcare): Hospital-affiliated oncology research network conducting community-based clinical trials. Comparable clinical research integration but embedded within a large hospital system rather than physician-owned.
• City of Hope: Major NCI-designated comprehensive cancer center offering integrated research-driven oncology care. Comparable comprehensive oncology service portfolio but operates at much larger academic scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/ocsri
• LinkedInlinkedin.com/company/ocsri

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oklahoma Cancer Specialists and Research Institute